News tagged with docetaxel
Gene assay to help to predict lung cancer treatment resistance
Aug 26, 2009 |
5 / 5 (1) |
0
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involv ...
New treatment combination proves safe for head and neck cancer patients
May 31, 2009 |
5 / 5 (1) |
0
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan ...
Survival predictors may help customize treatment options for men with metastatic prostate cancer
May 14, 2009 |
4.5 / 5 (2) |
0
Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center.
3-drug chemotherapy combination increases organ preservation in patients with larynx cancer
Mar 24, 2009 |
5 / 5 (1) |
0
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin ...
Search results for docetaxel
Docetaxel given after doxorubicin reduces recurrence
Jan 08, 2008 |
not rated yet |
0
Adding the drug docetaxel to anthracycline-based chemotherapy slightly improved disease-free survival in breast cancer patients, according to a randomized clinical trial published online January 8 in the Journal of the Na ...
Genes identified which predict response to breast cancer treatment
Sep 24, 2007 |
not rated yet |
0
Scientists in Aberdeen have identified two genes that identify which breast cancer cells are resistant and which respond to a common chemotherapy treatment.
Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
Jun 01, 2009 |
not rated yet |
0
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according ...
Targeting breast cancer stem cells in mice
Jun 02, 2009 |
5 / 5 (1) |
0
Cancer develops when cells known as cancer stem cells begin to divide in an uncontrolled manner. Researchers from the University of Michigan Comprehensive Cancer Center have identified roles for the gene PTEN, ...
Chemo-radiation before prostate removal may prevent cancer recurrence
Nov 04, 2009 |
5 / 5 (1) |
0
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is ...
Hormone inhibitor promising for hard-to-treat prostate cancer
Jul 08, 2007 |
4 / 5 (5) |
0
For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.
Studies suggest key correlation between lung cancer subtype and treatment outcomes
Sep 26, 2007 |
not rated yet |
0
In clinical research, patients with advanced non-small cell lung cancer (NSCLC) that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting ...
New treatment shows promise against recurrent gynecologic cancers
Apr 21, 2009 |
not rated yet |
0
(BRONX, NY) - Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already ...
OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
Jun 01, 2007 |
5 / 5 (1) |
0
PORTLAND, Ore. — Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as ...
Iressa proves just as effective as chemotherapy for lung cancer
Nov 21, 2008 |
2.5 / 5 (2) |
1
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, ...
List of search results for docetaxel
